REG - Breedon Group PLC - Result of AGM

BreedonAnnouncement

Today 17:01

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260429:nRSc4633Ca&default-theme=true

RNS Number : 4633C  Breedon Group PLC  29 April 2026

 

LEI: 213800DQGNQE3X76WS92

 

29 April 2026

BREEDON GROUP plc

(the Company)

 

Result of the Annual General Meeting

 

The Annual General Meeting of Breedon (the AGM) was held on 29 April 2026 at
Pinnacle House, Breedon on the Hill, Derby, DE73 8AP at 2:00pm, the Directors
are pleased to announce that the shareholders of Breedon Group plc passed all
the resolutions set out in the Notice of Meeting which were voted by way of a
poll. The total number of votes received for each resolution is set out below.

 

Resolutions 1 to 14 were passed as ordinary resolutions and resolutions 15 to
18 were passed as special resolutions.

 

In accordance with UKLR 6.4.2R, a copy of the resolutions passed at the AGM,
other than resolutions concerning ordinary business, will be submitted to the
National Storage Mechanism. These resolutions will shortly be available for
inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism
(https://protect.checkpoint.com/v2/r06/___https:/data.fca.org.uk/___.ZXV3MjpuZXh0MTU6YzpvZmZpY2UzNjVfZW1haWxzX2F0dGFjaG1lbnQ6MjI1ZjMzODViZDI1OTQ0MmQ0YzhkMGE4N2E0ZTBjNjI6Nzo2NjUyOmM3Mjc3MTYwNDIzMzVmMDIzYjM4NDEzNmZiMDNlOGUwZTMxZWI1YTZmYjhlMDM4MjQzMTkwNjJmYjAzZjZjOGQ6cDpGOlQ#/nsm/nationalstoragemechanism)
.

 

The percentages shown below are rounded to two decimal places.

 

All resolutions were duly passed on a poll and the results of each resolution
were as follows:

 

Ordinary resolutions:

                                                                                     Votes for    %      Votes against  % against  Votes withheld  Total votes cast   % of issued share capital voted

                                                                                                  for
 1   To receive the reports of the Directors and the Auditor for the financial year  292,841,215  99.99  3,825          0.01       1,279,025       292,845,040       84.37
     ended 31 December 2025
 2   To re-appoint the Auditor                                                       292,640,659  99.64  1,065,729      0.36       417,677         293,706,388       84.62
 3   To authorise the Directors to determine the fee payable to the Auditor          293,533,904  99.94  178,137        0.06       412,024         293,712,041       84.62
 4   To approve the Directors' Remuneration Report                                   286,434,169  97.52  7,274,048      2.48       415,848         293,708,217       84.62
 5   To approve a final dividend                                                     293,717,463  99.99  2,876          0.01       403,726         293,720,339       84.62
 6   To re-elect Amit Bhatia as a Director of the Company                            280,545,704  95.52  13,162,182     4.48       416,179         293,707,886       84.62
 7   To re-elect James Brotherton as a Director of the Company                       293,548,657  99.95  157,459        0.05       417,949         293,706,116       84.62
 8   To re-elect Carol Hui, OBE, as a Director of the Company                        291,371,497  99.47  1,555,158      0.53       1,197,410       292,926,655       84.39
 9   To re-elect Pauline Lafferty as a Director of the Company                       288,704,622  98.30  5,001,427      1.70       418,016         293,706,049       84.62
 10  To re-elect Helen Miles as a Director of the Company                            292,149,518  99.47  1,556,644      0.53       417,903         293,706,162       84.62
 11  To re-elect Clive Watson as a Director of the Company                           291,761,907  99.34  1,944,209      0.66       417,949         293,706,116       84.62
 12  To re-elect Rob Wood as a Director of the Company                               293,652,531  99.98  53,585         0.02       417,949         293,706,116       84.62
 13  To authorise the Directors to make political donations                          289,893,865  98.70  3,825,940      1.30       404,260         293,719,805       84.62
 14  To authorise the Directors to allot shares                                      289,231,400  98.47  4,484,943      1.53       407,722         293,716,343       84.62

 Special resolutions:
 15  To disapply pre-emption rights in relation to the allotment of shares           289,550,004  98.58  4,164,779      1.42       409,282         293,714,783       84.62
 16  To authorise the Directors to allot shares issued for an acquisition without    273,849,301  93.24  19,863,351     6.76       411,413         293,712,652       84.62
     applying pre-emption rights
 17  To authorise the Company to purchase its own shares                             293,653,357  99.99  26,887         0.01       443,821         293,680,244       84.61
 18  To authorise the Directors to call a general meeting in not less than 14 clear  291,154,463  99.13  2,562,717      0.87       406,885         293,717,180       84.62
     days' notice

 

 

 

Notes:

1.   Votes 'For' include those votes giving the Chair discretion.

2.   The number of ordinary shares in issue at 2.00pm on 27 April 2026 was
347,090,897; Shareholders are entitled to one vote per share.

3.   A vote withheld is not a vote in law and is not counted in the
calculation of the proportion of votes validly cast.

Enquiries:

 

Breedon Group
plc
www.breedongroup.com

James Atherton-Ham, Group General Counsel                 +44
(0) 1332 694000

Louise Turner-Smith, Head of Investor Relations             +44
(0) 7860 911909

 

MHP (Public Relations
Adviser)
+44 (0) 7508 012457

Reg Hoare, Rachel Farrington, Charles
Hirst                    breedon@mhpgroup.com
(mailto:breedon@mhpgroup.com)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  RAGILMATMTATBPF



            Copyright 2019 Regulatory News Service, all rights reserved